Renaissance Technologies
NXTC icon

Renaissance Technologies’s NextCure NXTC Stock Holding History

Renaissance Technologies’s Portfolio NXTC Stock Details NXTC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$647K Buy
60,534
+26,900
+80% +$329K ﹤0.01% 2491
2025
Q4 		$477K Buy
33,634
+5,300
+19% +$54.9K ﹤0.01% 2591
2025
Q3 		$166K Sell
28,334
-13,411
-32% -$70.2K ﹤0.01% 3169
2025
Q2 		$230K Buy
41,745
+1,748
+4% +$9.38K ﹤0.01% 3131
2025
Q1 		$231K Sell
39,997
-3,278
-8% -$28.9K ﹤0.01% 3037
2024
Q4 		$400K Buy
43,275
+9,442
+28% +$139K ﹤0.01% 2950
2024
Q3 		$556K Sell
33,833
-4,679
-12% -$86.1K ﹤0.01% 2740
2024
Q2 		$735K Buy
38,512
+5,145
+15% +$100K ﹤0.01% 2491
2024
Q1 		$893K Buy
33,367
+8,924
+37% +$154K ﹤0.01% 2553
2023
Q4 		$334K Buy
24,443
+3,593
+17% +$52.1K ﹤0.01% 2943
2023
Q3 		$323K Buy
20,850
+250
+1% +$4.77K ﹤0.01% 2899
2023
Q2 		$445K Buy
20,600
+225
+1% +$4.43K ﹤0.01% 2938
2023
Q1 		$362K Sell
20,375
-13,507
-40% -$260K ﹤0.01% 3037
2022
Q4 		$573K Buy
33,882
+14,715
+77% +$339K ﹤0.01% 2876
2022
Q3 		$633K Sell
19,167
-5,145
-21% -$262K ﹤0.01% 2779
2022
Q2 		$1.37M Buy
24,312
+11,912
+96% +$622K ﹤0.01% 2487
2022
Q1 		$723K Buy
12,400
+3,267
+36% +$204K ﹤0.01% 2945
2021
Q4 		$658K Sell
9,133
-22,042
-71% -$1.84M ﹤0.01% 2942
2021
Q3 		$2.52M Buy
31,175
+14,483
+87% +$1.27M ﹤0.01% 1914
2021
Q2 		$1.61M Buy
+16,692
New +$1.71M ﹤0.01% 2403
2020
Q3 		– Sell
-5,342
Closed -$1.37M – 3586
2020
Q2 		$1.37M Buy
+5,342
New +$2.03M ﹤0.01% 2389

Other funds holding NXTC

SCM
Squadron Capital Management Westmont, Illinois $273M AUM
AAA
Affinity Asset Advisors New York $1.94B AUM 374.45% 1-Year Est. Return
IC
Ikarian Capital Dallas, Texas $1.23B AUM 600.17% 1-Year Est. Return
SI
Sofinnova Investments Menlo Park, California $2.63B AUM 117.41% 1-Year Est. Return
SCM
Silverarc Capital Management Boston, Massachusetts $980M AUM 470.8% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
P
Pfizer New York $239M AUM 232.47% 1-Year Est. Return
OM
Opaleye Management Boston, Massachusetts $759M AUM 124.8% 1-Year Est. Return
AIC
AWM Investment Company New York $903M AUM 163.47% 1-Year Est. Return
EAM
Exome Asset Management New York $193M AUM 208.51% 1-Year Est. Return

Renaissance Technologies's NXTC Position: Q1 2026 in Review

Renaissance Technologies increased its NextCure (NXTC) stake by 80% in Q1 2026, buying an estimated $329K and bringing the position to 60,534 shares worth $647K. The position accounts for ﹤0.01% of the portfolio, ranked #2491.

Renaissance Technologies first reported a position in NXTC in Q2 2020 and has held it in 21 quarters since. The position peaked at $2.52M in Q3 2021. 26 funds tracked by Wall St. Rank hold NXTC as of Q1 2026.

  • Renaissance Technologies held 60,534 shares of NextCure worth $647K as of Q1 2026.
  • Renaissance Technologies bought 26,900 NextCure shares in Q1 2026, an estimated $329K.
  • NextCure made up ﹤0.01% of Renaissance Technologies's portfolio in Q1 2026, its #2491 holding.
  • Renaissance Technologies first reported a position in NextCure in Q2 2020 and has held it in 21 quarters since.
  • Renaissance Technologies's NextCure position peaked at $2.52M in Q3 2021.
  • 26 funds tracked by Wall St. Rank held NextCure as of Q1 2026.

Based on Renaissance Technologies's 13F filing for Q1 2026, filed 14 May 2026.